申请人:Okram Barun
公开号:US20110003798A1
公开(公告)日:2011-01-06
The invention provides a novel class of 2,7-naphthyridin derivatives; pharmaceutical compositions comprising such compounds and methods of using such compounds to treat o prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Syk, ZAP70, KDR, FMS, FLT*, c-Kit, RET, TrkA, TrkB, TrkC-GR-1R, Alk, c-FMS or combinations thereof.
本发明提供了一类新型的2,7-萘啶衍生物;包含这些化合物的药物组合物以及使用这些化合物治疗或预防与异常或调节不良的激酶活性相关的疾病或疾病的方法,特别是Syk,ZAP70,KDR,FMS,FLT*,c-Kit,RET,TrkA,TrkB,TrkC-GR-1R,Alk,c-FMS或其组合。